arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Neumora Therapeutics, Inc.

NMRA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.63
▼ -6.9% Today
as of Jun 7, 07:22 ET
Last 30 days -27.56% Apr 28 → Jun 05
$1.56 $1.81 $2.05 $2.29 $2.54 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.75
High
$1.75
Low
$1.61
Volume
$860,331
Avg Vol
$1M
Mkt Cap
$348M
P/E (TTM)
Beta
52w High
$3.65
52w Low
$0.72
Div Yield
Shares Out

Overview

52-week range
$0.72
$3.65
31% of range
Avg surprise (last 2)
+0.6%
Avg reaction (last 2)
-6.1%
50% positive
Latest IV / EM
266%
EM ±36.8% · $2 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.28$-1.04$-0.79$-0.55$-0.30 Actual $-1.28Actual $-1.14Actual $-0.34Actual $-0.37Actual $-0.45Actual $-0.42Est $-0.40Actual $-0.33Actual $-0.35Actual $-0.30Est $-0.32 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-73M$-68M$-64M$-60M$-55M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.30 $-0.32 +6.2% +28.6% -16.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.35 financials
Mon Jun 30, 2025Jun 2025 $-0.33 financials
Mon May 12, 2025Mar/2025 $-0.42 $-0.40 -5.0% +4.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.45 financials
Sun Jun 30, 2024Jun 2024 $-0.37 financials
Sun Mar 31, 2024Mar 2024 $-0.34 financials
Sat Sep 30, 2023Sep 2023 $-1.14 financials
Fri Jun 30, 2023Jun 2023 $-1.28 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-53M$-58M$-54M$-71M$-77M$-64M
Net income$-53M$-57M$-53M$-68M$-73M$-59M
EPS (diluted)$-0.30$-0.35$-0.33$-0.42$-0.45$-0.37

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$147M$183M$129M$125M$127M$142M$276M$151M
Inventory
Total current assets$153M$191M$177M$223M$255M$314M$349M$398M
Total assets$154M$191M$178M$224M$257M$317M$353M$404M
Long-term debt$53M$55M$20M$19M$0
Total liabilities$83M$87M$46M$41M$28M$30M$32M$23M
Total equity$71M$104M$132M$183M$228M$287M$321M$381M

Implied volatility — last 90 days

260%263%265%268%270% Jun 07 — IV 266% · EM ±36.8%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.